Introducing Clinical Research Services Turku (CRST)
A Cutting-Edge Partner in Medical Innovation
Clinical Research Services Turku (CRST) is a leading contract research organization offering several services to support and accelerate clinical studies. Committed to excellence, CRST can successfully enroll healthy volunteers and outpatients within agreed-upon timelines for different studies, making it an indispensable partner for pharmaceutical, biotechnology, and medical device companies.
Established in 1995 by Professors in Pharmacology and Clinical Pharmacology Mika Scheinin and Risto Huupponen and Professor of Biostatistics Juhani Tuominen, CRST is located in Turku, a vibrant hub of scientific and technological advancement. In 2020, CRST opened another branch in Helsinki to expand its reachability and services. These strategic locations provide CRST with access to world-class research facilities, a network of experts, and a supportive ecosystem that fosters collaboration and growth.
At the heart of CRST’s mission lies its ability to design and conduct Phase I-IV trials tailored to the client’s needs. By leveraging their vast expertise in various therapeutic areas, CRST assists in study protocol development, patient recruitment, and site selection while strictly adhering to regulatory requirements. This commitment ensures that trials are conducted with utmost precision, integrity, and adherence to ethical standards.
With its state-of-the-art capabilities and global perspective, CRST is poised to impact the future of healthcare. By partnering with CRST, researchers and pharmaceutical companies can direct research to bring life-changing therapies and treatments to patients.
Turku Brain and Mind Center had the opportunity to visit CRST’s office in Turku and to discuss future connection and further partnership with our researchers as a productive step towards industrial collaboration.
In the picture, from left to right, Professor Mika Scheinin, Chief Scientific Officer, Hanna-Mari Koskimaa, Chief Subject Recruitment Officer, and Hannah Liuska, TBMC Development Manager.
For more information:
Clinical Trials (Finnish)
Memory Drug Trials (Finnish)